Skip to main content

Table 2 Pre- and post-test receptivity, intention, and likelihood of participating in clinical trials

From: Effectiveness of a short video-based educational intervention on factors related to clinical trial participation in adolescents and young adults: a pre-test/post-test design

 

Pre-test

Post-test

Difference in proportions** (95% CI)

 

n

Median

IQR

n

Median

IQR

p***

Receptivity*

 Total sample

931

2

1.00, 2.00

933

1

1.00, 2.00

0.06 (0.03, 0.08)

< 0.0001

 White

646

2

1.00, 2.00

646

1

1.00, 2.00

0.05 (0.02, 0.07)

< 0.0001

 African American

187

2

1.00, 3.00

189

2

1.00, 2.00

0.11 (0.04, 0.18)

0.02

Intention*

 Total sample

930

3

2.00, 3.00

932

2

2.00, 3.00

0.18 (0.15, 0.22)

< 0.0001

 White

645

3

2.00, 3.00

646

2

2.00, 3.00

0.20 (0.16, 0.24)

< 0.0001

 African American

187

2

2.00, 3.00

188

2

2.00, 3.00

0.13 (0.05, 0.22)

0.03

Participate in hypothetical trial*

 Total sample

930

3

2.00, 4.00

929

4

2.00, 4.00

0.15 (0.12, 0.18)

< 0.0001

 White

645

3

2.00, 4.00

644

4

3.00, 4.00

0.14 (0.10, 0.17)

< 0.0001

 African American

187

3

2.00, 4.00

187

3

2.00, 4.00

0.16 (0.08, 0.23)

< 0.0001

  1. CI confidence interval, IQR interquartile range
  2. *Lower scores indicate greater receptivity to hearing more about a relevant clinical trial, greater intention to participate, and lower likelihood of participation in a hypothetical clinical trial
  3. **Proportion receptive to hearing more about clinical trials, intent to participate, and likely to enroll in a hypothetical clinical trial: difference between dichotomous post- and pre-test values along with adjusted Wald 95% confidence intervals
  4. ***From Wilcoxon signed-rank test applied to pre-test and post-test comparison